Therapeutic Peptides
Therapeutic peptides are a class of bioactive molecules formed by amino acids linked through peptide bonds, representing an important branch of the biopharmaceutical field. Their core advantages include precise structure, strong targeting capability, and low side effects, making them widely applicable in areas such as oncology, metabolic diseases, and immunomodulation.
Synbio Technologies provides an extensive portfolio of ready-to-ship therapeutic peptide products, all backed by accurate and timely delivery.
Highlights
-
![]()
- Extensive Peptide Diversity
-
![]()
- Purity Level ≥98.0%
-
![]()
- Multiple Quality Controls
-
![]()
- Fast Turnaround
Product List
|
Peptide
|
Cas No
|
Molecular Formula
|
Molecular Weight
|
Sequence
|
Purity
|
Storage
|
|
BPC-157
|
137525-51-0
|
C62H98N16O22
|
1419.54
|
H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH
|
≥ 98.0%
|
Keep in dark and cool
dry place
|
|
CJC-1295
|
863288-34-0
|
C152H252N44O42
|
3367.90
|
H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
|
≥ 98.0%
|
|
DSIP
|
62568-57-4
|
C35H48N10O15
|
848.81
|
H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH
|
≥ 98.0%
|
|
Epitalon (AEDG)
|
307297-39-8
|
C14H22N4O9
|
390.34
|
H-Ala-Glu-Asp-Gly-OH
|
≥ 98.0%
|
|
GHK-Cu
|
89030-95-5
|
C14H22N6O4Cu
|
401.91
|
H-Gly-His-Lys-OH · Cu
|
≥ 98.0%
|
|
Ipamorelin
|
170851-70-4
|
C38H49N9O5
|
711.85
|
Aib-His-D-2-Nal-D-Phe-Lys-NH2
|
≥ 98.0%
|
|
MOTS-C
|
1627580-64-6
|
C101H152N28O22S2
|
2174.59
|
H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH
|
≥ 98.0%
|
|
Selank
|
129954-34-3
|
C33H57N11O9
|
751.87
|
H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH
|
≥ 98.0%
|
|
Semax
|
80714-61-0
|
C37H51N9O10S
|
813.92
|
H-Met-Glu-His-Phe-Pro-Gly-Pro-OH
|
≥ 98.0%
|
|
SS-31
|
736992-21-5
|
C32H49N9O
|
639.79
|
D-Arg-Dmt-Lys-Phe-NH2
|
≥ 98.0%
|
|
TB-500
|
77591-33-4
|
C212H350N56O78S
|
4963.44
|
Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH
|
≥ 98.0%
|
|
Tesamorelin
|
218949-48-5
|
C221H366N72O67S
|
5135.86
|
trans-3-Hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gl n-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
|
≥ 98.0%
|
|
Thymosin Alpha-1
|
62304-98-7
|
C129H215N33O55
|
3108.28
|
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
|
≥ 98.0%
|
*For ≤ 100g in stock, for >100g Quote
Deliverables
-
Peptide Products
-
HPLC Reports
-
MS Reports
-
Certificate of Analysis
FAQs
Therapeutic peptides are produced under drug development requirements and are intended for clinical use. Compared to standard research peptides, they have stricter quality control, process stability, and regulatory compliance. Therapeutic peptides must be manufactured under GMP conditions and meet all quality and safety standards required by regulatory agencies.
We have a robust quality control system with advanced instruments (HPLC, LC-MS, MS/MS). All starting materials, intermediates, and final products undergo thorough testing. Each product is accompanied by a detailed COA including HPLC purity and mass spectrometry data.
Get in Touch with Us
Related Services
DNA Synthesis
Vector Selection
Molecular Biology
Oligo Synthesis
RNA Synthesis
Variant Libraries
Genome KO Library
Oligo Pools
Virus Packaging
Gene Editing
Protein Expression
Antibody Services
Peptide Services
DNA Data Storage
Standard Oligo
Standard Genome KO Libraries
Standard Genome Editing Plasmid
ProXpress
Protein Products
